Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia

References

• Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, Doolman R, Asraf K, Mendelson E, Ziv A, et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N Engl J Med. 2021;385(24):e84. doi:10.1056/NEJMoa2114583.
   PubMed Web of Science ®Google Scholar
• Naaber P, Tserel L, Kangro K, Sepp E, Jürjenson V, Adamson A, Haljasmägi L, Rumm AP, Maruste R, Kärner J, et al. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. Lancet. 2021;10:100208. doi:10.1016/j.lanepe.2021.100208.
   Web of Science ®Google Scholar
• Altmann DM, Boyton RJ. Waning immunity to SARS-CoV-2: implications for vaccine booster strategies. Lancet. 2021;9:1356–9. doi:10.1016/S2213-2600(21)00458-6.
   Web of Science ®Google Scholar
• Mohapatra RJ, El-Shall NA, Tiwari R, Nainu F, Ramana KV, Sarangi AK, Mohamed TA, Designu PA, Chakraborty C, Dhama K. 2022. Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: an update. Hum Vaccines Immunother. [Under publication].
   PubMed Web of Science ®Google Scholar
• Omer SB, Malani PN. Booster vaccination to prevent COVID-19 in the era of omicron: an effective part of a layered public health approach. JAMA. 2022;327(7):628–29. doi:10.1001/jama.2022.0892.
   PubMed Web of Science ®Google Scholar
• Wald A. Booster vaccination to reduce SARS-CoV-2 transmission and infection. JAMA. 2022;327(4):327–28. doi:10.1001/jama.2021.23726.
   PubMed Web of Science ®Google Scholar
• Munro AP, Janani L, Cornelius V, Aley PK, Babbage G, Baxter D, Bula M, Cathie K, Chatterjee K, Dodd K, et al. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdox1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet. 2021;398(10318):2258–76. doi:10.1016/S0140-6736(21)02717-3.
   PubMed Web of Science ®Google Scholar
• Department of Statistics Malaysia. Current population estimates Malaysia. 2021 July 15 [accessed 2022 Mar 12]. https://www.dosm.gov.my/v1/index.php?r=column/cthemeByCat&cat=155&bul_id=ZjJOSnpJR21sQWVUcUp6ODRudm5JZz09&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09 .
   Google Scholar
• WHO. Malaysia Coronavirus disease 2019 (COVID-19) situation report weekly report for the week ending. 2021 Mar 28 [accessed 2022 Mar 12]. https://www.who.int/docs/default-source/wpro-documents/countries/malaysia/coronavirus-disease-%28covid-19%29-situation-reports-in-malaysia/covid19_sitrep_mys_20210328_final.pdf?sfvrsn=7957aad9_4&download=true .
   Google Scholar
• Dasgupta S. Independent. Malaysia government tells those who choose not to get Covid vaccine: ‘We will make life very difficult. 2021 Oct 18 [accessed 2022 Apr 21]. https://www.independent.co.uk/asia/southeast-asia/covid-malaysia-unvaccinated-health-ministry-b1940110.html .
   Google Scholar
• COVIDNOW. Vaccinations in Malaysia. 2022 Mar 16 [accessed 2022Mar 12]. https://covidnow.moh.gov.my/vaccinations/ .
   Google Scholar
• Wong LP, Alias H, Danaee M, Ahmed J, Lachyan A, Cai CZ, Lin Y, Hu Z, Tan SY, Lu Y, et al. COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries. Infect Dis Poverty. 2021;10(1):122. doi:10.1186/s40249-021-00900-w.
   PubMed Web of Science ®Google Scholar
• Lau JF, Woon YL, Leong CT, Teh HS. Factors influencing acceptance of the COVID-19 vaccine in Malaysia: a web-based survey. Osong Public Health Res Perspect. 2021;12(6):361–73. doi:10.24171/j.phrp.2021.0085.
   PubMedGoogle Scholar
• Syed Alwi SA, Rafidah E, Zurraini A, Juslina O, Brohi IB, Lukas S. A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC Public Health. 2021;21(1):1129. doi:10.1186/s12889-021-11071-6.
   PubMed Web of Science ®Google Scholar
• Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccines Immunother. 2020;16(9):2204–14. doi:10.1080/21645515.2020.1790279.
   PubMed Web of Science ®Google Scholar
• WHO Europe. Pandemic fatigue. Reinvigorating the public to prevent COVID-19. 2020 [accessed 2022 Mar 12]. https://apps.who.int/iris/bitstream/handle/10665/335820/WHO-EURO-2020-1160-40906-55390-eng.pdf .
   Google Scholar
• Reicher S, Drury J. Pandemic fatigue? How adherence to covid-19 regulations has been misrepresented and why it matters. BMJ. 2021;372(n137). doi:10.1136/bmj.n137.
   PubMedGoogle Scholar
• Lindholt MF, Jørgensen F, Bor A, Petersen MB. Public acceptance of COVID-19 vaccines: cross-national evidence on levels and individual-level predictors using observational data. BMJ Open. 2021;11(6):e048172. doi:10.1136/bmjopen-2020-048172.
   PubMed Web of Science ®Google Scholar
• Ala’a B, Tarhini Z, Akour A. A swaying between successive pandemic waves and pandemic fatigue: where does Jordan stand? Ann Med Surg. 2021;65:102298. doi:10.1016/j.amsu.2021.102298.
   PubMed Web of Science ®Google Scholar
• Wolff K. COVID-19 vaccination intentions: the theory of planned behavior, optimistic bias, and anticipated regret. Front Psychol. 2021;12:648289. doi:10.3389/fpsyg.2021.648289.
   PubMed Web of Science ®Google Scholar
• Thaker J, Ganchoudhuri S. The role of attitudes, norms, and efficacy on shifting COVID-19 vaccine intentions: a longitudinal study of COVID-19 vaccination intentions in New Zealand. Vaccines. 2021;9(10):1132. doi:10.3390/vaccines9101132.
   Web of Science ®Google Scholar
• Shmueli L. Predicting intention to receive COVID-19 vaccine among the general population using the health belief model and the theory of planned behavior model. BMC Public Health. 2021;21(1):1–3. doi:10.1186/s12889-021-10816-7.
   PubMed Web of Science ®Google Scholar
• Zhang KC, Fang Y, Cao H, Chen H, Hu T, Chen Y, Zhou X, Wang Z. Behavioral intention to receive a COVID-19 vaccination among Chinese factory workers: cross-sectional online survey. J Med Internet Res. 2021;23(3):e24673. doi:10.2196/24673.
   PubMed Web of Science ®Google Scholar
• Cerda AA, García LY. Hesitation and refusal factors in individuals’ decision-making processes regarding a coronavirus disease 2019 vaccination. Front Public Health. 2021;9:9. doi:10.3389/fpubh.2021.626852.
   Web of Science ®Google Scholar
• Norhayati MN, Yusof RC, Azman YM. Systematic review and meta-analysis of COVID-19 vaccination acceptance. Front Med. 2021:8. doi:10.3389/fmed.2021.783982.
   Web of Science ®Google Scholar
• Raosoft. Sample size calculator by Raosoft. 2017 [accessed 2021 Aug 18]. http://www.raosoft.com/samplesize.html .
   Google Scholar
• Daniel WW. Biostatistics: a foundation for analysis in the health sciences. 7th ed. New York (NY): John Wiley & Sons; 1999.
   Google Scholar
• Department of Statistics Malaysia. Launching of report on the key findings population and housing census of Malaysia 2020. 2022Feb 14 [accessed 2022 Mar 13]. https://www.dosm.gov.my/v1/index.php?r=column/cthemeByCat&cat=117&bul_id=akliVWdIa2g3Y2VubTVSMkxmYXp1UT09&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09 .
   Google Scholar
• Wejnert C, Pham H, Krishna N, Le B, DiNenno E. Estimating design effect and calculating sample size for respondent-driven sampling studies of injection drug users in the United States. AIDS Behav. 2012;16(4):797–806. doi:10.1007/s10461-012-0147-8.
   PubMed Web of Science ®Google Scholar
• Lilleholt L, Zettler I, Betsch C, Böhm R. 2020. Pandemic fatigue: measurement, correlates, and consequences. Psy Arvix. [ Preprint].
   Google Scholar
• MySejahtera. Introduction. 2021 [accessed 2022 Apr 21]. https://mysejahtera.malaysia.gov.my/intro_en/ .
   Google Scholar
• Al-Qerem W, Al Bawab AQ, Hammad A, Ling J, Alasmari F. Willingness of the Jordanian population to receive a COVID-19 booster dose: a cross-sectional study. Vaccines. 2022;10(3):410. doi:10.3390/vaccines10030410.
   Web of Science ®Google Scholar
• Yadete T, Batra K, Netski DM, Antonio S, Patros MJ, Bester JC. Assessing acceptability of COVID-19 vaccine booster dose among adult Americans: a cross-sectional study. Vaccines. 2021;9(12):1424. doi:10.3390/vaccines9121424.
   PubMed Web of Science ®Google Scholar
• Rzymski P, Poniedziałek B, Fal A. Willingness to receive the booster COVID-19 vaccine dose in Poland. Vaccines. 2021;9(11):1286. doi:10.3390/vaccines9111286.
   PubMed Web of Science ®Google Scholar
• Tung TH, Lin XQ, Chen Y, Zhang MX, Zhu JS. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China. Expert Rev Vaccines. 2021. doi:10.1080/14760584.2022.2016401.
   Web of Science ®Google Scholar
• Daud S. The COVID-19 pandemic crisis in Malaysia and the social protection program. J Dev Soc. 2021;37:480–501. doi:10.1177/0169796X211041154.
   Web of Science ®Google Scholar
• Chen JA, Zhang E, Liu CH. Potential impact of COVID-19–related racial discrimination on the health of Asian Americans. Am J Public Health. 2020;110(11):1624–27. doi:10.2105/AJPH.2020.305858.
   PubMed Web of Science ®Google Scholar
• Gruer L, Agyemang C, Bhopal R, Chiarenza A, Krasnik A, Kumar B Migration, ethnicity, racism and the COVID-19 pandemic: a conference marking the launch of a new global society. Public Health Pract (Oxf). 2021;2:100088. doi:10.1016/j.puhip.2021.100088.
   PubMedGoogle Scholar
• Mohamed NA, Solehan HM, Mohd Rani MD, Ithnin M, Che Isahak CI, Sobh E. Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: a web-based survey. Plos One. 2021;16(8):e0256110. doi:10.1371/journal.pone.0256110.
   PubMed Web of Science ®Google Scholar
• Din HM, Adnan RN, Akahbar SA, Ahmad SA. Characteristics of COVID-19-related deaths among older adults in Malaysia. Malays J Med Sci. 2021;28(4):138–45. doi:10.21315/mjms2021.28.4.14.
   PubMed Web of Science ®Google Scholar
• Wong LP, Alias H, Tan YR, Tan KM. Older people and responses to COVID‐19: a cross‐sectional study of prevention practices and vaccination intention. Int J Older People Nurs. 2021:e12436. doi:10.1111/opn.12436.
   PubMed Web of Science ®Google Scholar
• Mattiuzzi C, Lippi G. Efficacy of COVID-19 vaccine booster doses in older people. Eur Geriatr Med. 2022;13(1):275–78. doi:10.1007/s41999-022-00615-7.
   PubMed Web of Science ®Google Scholar
• Petherick A, Goldszmidt R, Andrade EB, Furst R, Hale T, Pott A, Wood A. A worldwide assessment of changes in adherence to COVID-19 protective behaviours and hypothesized pandemic fatigue. Nat Hum Behav. 2021;5:1145–60. doi:10.1038/s41562-021-01181-x.
   PubMed Web of Science ®Google Scholar
• Kementerian Kesihatan Malaysia. Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin Covid-19 Sehingga 11/03/2022. 2022 Mar 16 [accessed 2022 Mar 14]. https://covid-19.moh.gov.my/semasa-kkm/2022/03/status-laporan-kesan-advers-susulan-imunisasi-aefi-vaksin-covid-19-sehingga-11-03-2022 .
   Google Scholar
• Wright KB. Researching internet-based populations: advantages and disadvantages of online survey research, online questionnaire authoring software packages, and web survey services. JCMC 2005;10:1034. https://doi.org/10.1111/j.1083-6101.2005.tb00259.x .
   Google Scholar